Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 1
2005 3
2007 3
2008 4
2009 2
2010 3
2012 2
2013 3
2015 2
2016 2
2017 12
2018 10
2019 12
2020 19
2021 17
2022 21
2023 21
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.
Aziz F, Tripolt NJ, Pferschy PN, Scharnagl H, Abdellatif M, Oulhaj A, Benedikt M, Kolesnik E, von Lewinski D, Sourij H. Aziz F, et al. Among authors: von lewinski d. Cardiovasc Diabetol. 2024 Apr 27;23(1):145. doi: 10.1186/s12933-024-02221-2. Cardiovasc Diabetol. 2024. PMID: 38678253 Free PMC article. Clinical Trial.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrøm SZ, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Verma S, Einfeldt MN, Lindegaard ML, Rasmussen S, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Kosiborod MN; STEP-HFpEF Trial Committees and Investigators. Butler J, et al. Among authors: von lewinski d. Lancet. 2024 Apr 27;403(10437):1635-1648. doi: 10.1016/S0140-6736(24)00469-0. Epub 2024 Apr 7. Lancet. 2024. PMID: 38599221 Clinical Trial.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Treppendahl MB, Verma S, Jensen TJ, Liisberg K, Lindegaard ML, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Shah SJ; STEP-HFpEF DM Trial Committees and Investigators. Kosiborod MN, et al. Among authors: von lewinski d. N Engl J Med. 2024 Apr 18;390(15):1394-1407. doi: 10.1056/NEJMoa2313917. Epub 2024 Apr 6. N Engl J Med. 2024. PMID: 38587233 Clinical Trial.
Impact of the Timing of Mechanical Circulatory Support on the Outcomes in Myocardial Infarction-Related Cardiogenic Shock: Subanalysis of the PREPARE CS Registry.
Prunea DM, Bachl E, Herold L, Kanoun Schnur SS, Pätzold S, Altmanninger-Sock S, Sommer GA, Glantschnig T, Kolesnik E, Wallner M, Ablasser K, Bugger H, Buschmann E, Praschk A, Fruhwald FM, Schmidt A, von Lewinski D, Toth GG. Prunea DM, et al. Among authors: von lewinski d. J Clin Med. 2024 Mar 8;13(6):1552. doi: 10.3390/jcm13061552. J Clin Med. 2024. PMID: 38541778 Free PMC article.
Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
Verheyen N, Schmid J, Kolesnik E, Schwegel N, Späth J, Kattnig L, Riepl H, Zach D, Santner V, Höller V, Pilz S, Tomaschitz A, Fuchsjäger M, Fahrleitner-Pammer A, Dimai HP, Obermayer-Pietsch B, Fruhwald F, Scherr D, Zirlik A, von Lewinski D, Ablasser K. Verheyen N, et al. Among authors: von lewinski d. ESC Heart Fail. 2024 Mar 7. doi: 10.1002/ehf2.14741. Online ahead of print. ESC Heart Fail. 2024. PMID: 38450879 Free article.
Special Issue "Coronary Artery Disease Interventions".
Herold L, Toth GG, von Lewinski D. Herold L, et al. Among authors: von lewinski d. J Clin Med. 2024 Jan 31;13(3):817. doi: 10.3390/jcm13030817. J Clin Med. 2024. PMID: 38337511 Free PMC article.
Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial.
Sourij C, Oulhaj A, Aziz F, Tripolt NJ, Aberer F, Pferschy PN, Postula M, Drexel H, Benedikt M, Kolesnik E, Pieber TR, Bugger H, von Lewinski D, Sourij H. Sourij C, et al. Among authors: von lewinski d. Diabetes Obes Metab. 2024 May;26(5):1971-1975. doi: 10.1111/dom.15477. Epub 2024 Jan 29. Diabetes Obes Metab. 2024. PMID: 38287198 Clinical Trial. No abstract available.
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort.
von Lewinski D, Herold L, Bachl E, Bugger H, Glantschnig T, Kolesnik E, Verheyen N, Benedikt M, Wallner M, von Lewinski F, Schmidt A, Harb S, Ablasser K, Sacherer M, Scherr D, Manninger-Wünscher M, Pätzold S, Gollmer J, Zirlik A, Toth GG. von Lewinski D, et al. J Clin Med. 2023 Nov 8;12(22):6988. doi: 10.3390/jcm12226988. J Clin Med. 2023. PMID: 38002602 Free PMC article.
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.
Butler J, Abildstrøm SZ, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Verma S, Abhayaratna WP, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Núñez J, Perna E, Schou M, Senni M, van der Meer P, von Lewinski D, Wolf D, Altschul RL, Rasmussen S, Kosiborod MN. Butler J, et al. Among authors: von lewinski d. J Am Coll Cardiol. 2023 Nov 28;82(22):2087-2096. doi: 10.1016/j.jacc.2023.09.811. Epub 2023 Oct 8. J Am Coll Cardiol. 2023. PMID: 37993201 Free article.
139 results